Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders
Grace Y Lam, Brendan P Halloran, Anthea C Peters, Richard N Fedorak
Grace Y Lam, Department of Medicine, Division of Internal Medicine, University of Alberta, 8440 112 St NW Edmonton, Alberta, Canada
Brendan P Halloran, Richard N Fedorak, Department of Medicine, Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, 8440 112 St NW Edmonton, Alberta, Canada
Anthea C Peters, Department of Medicine, Division of Hematology, University of Alberta, 8440 112 St NW Edmonton, Alberta, Canada
Author contributions: Lam GY, Halloran BP, Peters AC and Fedorak RN contributed equally to this work.
Conflict-of-interest statement: Lam GY has no conflicts of interest to declare. Peters AC has been an advisory board member for Janssen, Roche, Lundbeck and Seattle Genetics. Halloran BP is a consultant and/or advisory board member for Abbvie and Janssen. Fedorak RN is a consultant or advisory board member of Abbvie, Ferring, Janssen, Shire, VSL#3, Celltrion. He is also the recipient of the following clinical/basic science research grants: Abbvie, Alba, Bristol Myers Squibb, Centocor, GSK, Genentec, Janssen, Merck, Millennium, Novartis, Pfizer, Proctor and Gamble, Roche, VSL#3, Celltrion. Finally, he is also the owner/Shareholder of Metablolomic Technologies Inc (www.metabolomictechnologies.ca).
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Brendan P Halloran, Department of Medicine, Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, 130 University Campus NW, 8440 112 St NW Edmonton, Alberta, Canada. brendan@ualberta.ca
Telephone: +1-780-4928691 Fax: +1-780-4928121
Received: March 31, 2015
Peer-review started: March 31, 2015
First decision: April 23, 2015
Revised: June 14, 2015
Accepted: August 30, 2015
Article in press: September 28, 2015
Published online: November 15, 2015
Processing time: 52 Days and 22 Hours
